The program is comprised of ten sessions: 

1. Challenges in Breast Cancer Management: Recurrent Disease, Reconstruction and Hypofractionation
   • Radiation Treatment of Recurrent Breast Cancer - Jose Bazan, MD, MS
   • Reconstructive Surgery and Recurrent Breast Cancer - David Chang, MD
   • Hypofractionation in Post-mastectomy Patients - Rinaa Punglia, MD, FASTRO, MPH
2. Beyond the First Dose: Re-irradiation for Brain Tumors - Maximizing Outcomes and Managing Risk
   • Re-irradiation of Primary Brain Tumors - Tips and Techniques - Daniel Trifiletti, MD
   • Re-irradiation of Brain Metastases: When and How - Joshua Palmer, MD
   • Mitigation and Management of Toxicity in the Re-irradiation of Brain Tumors - Christina Cramer, MD
3. Bones of Contention: Navigating Innovations in Real-World Management of Non-Spine Bone Metastases
   • Targeting Precision: Harnessing SBRT for Non-Spinal Bone Metastases - Winston Vuong, MD
   • Prophylactic Palliation: Radiation Asymptomatic Bone Metastases as the Evidence Still Emerges - Jonathan Yang, MD, PhD
   • Navigating the Maze: SBRT Advocacy, Retreatment Strategies and Alternative Approaches - Zachary Kohutek, MD, PhD
4. Liquid Biopsies in Cancer
   • ctDNA for Blood-based Noninvasive Genotyping - Scott Bratman, MD, PhD
   • Liquid Biopsy Early Detection of Cancer - Aadel Chaudhuri, MD, PhD
   • Liquid Biopsies for Detection of Minimal Residual Disease - Maximilian Diehn, MD, PhD
5. Driving Engagement and Delivering Value: A Strategic Dialogue with ASTRO CEO
   • Vivek Kavadi, MD, MBA, FASTRO 
6. Micro- and Macroeconomics of Radiation Oncology Practice
   • Billing 101 - Christopher Jahraus, MD, FASTRO
   • Clinicial Workflow: How the Structure of your Practice Can Cost You - Beant Gill, MD
   • Alternative Payment Models and Economic Changes on the Horizon - Catheryn Yashar, MD, FASTRO
7. Indolent Lymphomas: Radiation Oncology Considerations
   • Nuts and Bolts of Indolent Lymphomas (clinicopathology, staging, prognosis) - Yolanda Tseng, MD
   • Toxicity Reduction Efforts with Radiation Therapy - Chelsea Pinnix, MD, PhD
   • Who and When - Indications for RT - Ari Wijetunga, MD, PhD, MS
8. The Journey of the Unknown Primary in the HPV Era: Evaluation, Treatment, Surveillance and Management of Oligometastatic Disease
   • Workup and Treatment of Unknown Primary p16 Positive Head and Neck Cancer Squamous Cell Carcinoma - Jessica Lee, MD
   • Surveillance of p16 Positive Head and Neck Squamous Cell Carcinoma: Examination, Imaging, and Biomarkers - Edina Wang, MD
   • Management of Oligometastatic Head and Neck Cancers in the Era of HPV - Musaddig Awan, MD 
9. Precision Radiotherapy for Liver and Pancreatic Malignancies: Indications, Techniques and Response Evaluation
   • Ablative Radiation Therapy for Locally Advanced Pancreas Cancer: Clinical Indications and Practical Considerations - Michael Chuong, MD
   • Integrating Radiotherapy into Multidisciplinary Care for Hepatocellular Carcinoma - Nina Sanford, MD
   • Post Radiotherapy Imaging and Response Evaluation in Hepatobiliary Cancer/Metastases - Smith Apisarnthanarax, MD
10. Practical Management Strategies for Advanced Stage Gynecologic Cancer Patients
    • Radiotherapy Across the Spectrum of Metastatic GYN Malignancies - Kevin Albuquerque, MD
    • Salvaging the Primary: Definitive Reirradiation or Palliation? - Dominique Rash, MD
    • Management of Sexual Side Effects of Radiotherapy and Progressive Disease for the Advanced Stage Patient - Sage Bolte, PhD 
11. Reviving the Value of Radiation Therapy in Cutaneous Squamous Cell Carcinoma (cSCCa): From Early to Late Stage Disease and Everything in Between

• The Role of Definitive Radiation for Early Stage cSCCa - Shauna Campbell, DO
• The Role of Adjuvant Radiation in cSCCa - Lisa McGee, MD
• Practical Updates in Systemic Therapy for Locally Advanced Cutaneous SCC: Peri-Operative Immunotherapy, Chemoradiation, and Immunotherapy-Radiation Combinations - Jeremy Harris, MD, MPhil    

This activity is available from December 1, 2025, through 11:59 p.m. Eastern time on December 31, 2026.

This activity was originally recorded at the 2025 ASTRO Annual Meeting.